IGM Biosciences Cash from Investing (TTM) Insights

IGM Biosciences Inc (IGMS)

9.40 +1.75 (+22.88%) USD | NASDAQ | Apr 26, 16:00

9.41 +0.01 (+0.11%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	68.36M
September 30, 2023	64.24M
June 30, 2023	40.94M
March 31, 2023	-136.72M
December 31, 2022	-225.64M
September 30, 2022	-204.59M
June 30, 2022	-247.96M
March 31, 2022	-43.25M
December 31, 2021	15.46M

Date	Value
September 30, 2021	34.45M
June 30, 2021	93.04M
March 31, 2021	69.37M
December 31, 2020	58.29M
September 30, 2020	-106.67M
June 30, 2020	-176.51M
March 31, 2020	-173.99M
December 31, 2019	-203.24M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-247.96M

Minimum

Jun 2022

93.04M

Maximum

Jun 2021

-63.20M

Average

-43.25M

Median

Mar 2022

Cash from Investing (TTM) Benchmarks